People with cognitive impairments have fewer gut microbes and less microbial diversity. That’s good news because we can ...

The revisions signal a shift toward looking at MS more as a biologically based disease, noted Xavier Montalban, MD, PhD, of ...

CADASIL is a brain disease involving genetic mutations, stroke, and dementia. Learn about symptom progression and ongoing ...

BOSTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, announced that Craig Thompson, chief ...

“Our discovery of RORB for these selectively vulnerable cells gives us the opportunity to study in detail exactly why they ...

The project, by scientists at Nottingham Trent University, will look at whether treatment can be delivered to the brain via ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

The symptoms of Alzheimer’s, Parkinson’s and dementia are well recognised, however what causes the disease is still unknown. Cases of dementia are on the rise and it is predicted that by 2040, 1.6 ...

A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | ...

A new study by scientists at Nottingham Trent University will use non-invasive techniques to investigate the targeted ...

A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...